Company
HTFL · CIK 0001464521
Acquisition (code M) of 12,329 shares at $8.33 per share.
Reporting Person Rogers Campbell · Officer Title Chief Medical Officer · Transaction Code M
Traded Sep 18, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001464521-26-000152 · filed 2026-09-21 · View filing →
Acquisition (code M) of 850 shares at $2.22 per share.
Reporting Person Rogers Campbell · Officer Title Chief Medical Officer · Transaction Code M
Traded Sep 18, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001464521-26-000152 · filed 2026-09-21 · View filing →
Sale of 19,682 shares at $50.15 per share.
Reporting Person Rogers Campbell · Officer Title Chief Medical Officer · Transaction Code S
Traded Sep 18, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001464521-26-000152 · filed 2026-09-21 · View filing →
Sale of 16,766 shares at $50.7531 per share.
Reporting Person Verghese Vikram · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 18, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001464521-26-000149 · filed 2026-09-18 · View filing →
Sale of 7,579 shares at $50.1142 per share.
Reporting Person Verghese Vikram · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001464521-26-000149 · filed 2026-09-18 · View filing →
Sale of 668 shares at $50.012 per share.
Reporting Person Verghese Vikram · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001464521-26-000147 · filed 2026-09-15 · View filing →
Sale of 4,593 shares at $50.2381 per share.
Reporting Person Verghese Vikram · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001464521-26-000147 · filed 2026-09-15 · View filing →
Sale of 29,714 shares at $50.0592 per share.
Reporting Person Verghese Vikram · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001464521-26-000147 · filed 2026-09-15 · View filing →
Sale of 3,890 shares at $50.00 per share.
Reporting Person Farquhar John C.M. · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 14, 2026
Source: SEC Form 4 · 0001464521-26-000145 · filed 2026-09-14 · View filing →
Sale of 35,010 shares at $46.4183 per share.
Reporting Person Farquhar John C.M. · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 10, 2026 · Disclosed Sep 14, 2026
Source: SEC Form 4 · 0001464521-26-000145 · filed 2026-09-14 · View filing →
Sale of 6,640 shares at $50.0319 per share.
Reporting Person Verghese Vikram · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0001464521-26-000143 · filed 2026-09-10 · View filing →
Sale of 27,540 shares at $49.6903 per share.
Reporting Person Verghese Vikram · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001464521-26-000141 · filed 2026-09-04 · View filing →
Sale of 5,876 shares at $50.60 per share.
Reporting Person Verghese Vikram · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001464521-26-000141 · filed 2026-09-04 · View filing →
Sale of 27,230 shares at $50.00 per share.
Reporting Person Farquhar John C.M. · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 21, 2026 · Disclosed Aug 25, 2026
Source: SEC Form 4 · 0001464521-26-000139 · filed 2026-08-25 · View filing →
Sale of 32,676 shares at $45.00 per share.
Reporting Person Farquhar John C.M. · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001464521-26-000137 · filed 2026-08-20 · View filing →
Acquisition (code M) of 9,219 shares at $19.00 per share.
Reporting Person Rogers Campbell · Officer Title Chief Medical Officer · Transaction Code M
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001464521-26-000135 · filed 2026-08-19 · View filing →
Sale of 9,219 shares at $41.23 per share.
Reporting Person Rogers Campbell · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001464521-26-000135 · filed 2026-08-19 · View filing →
Sale of 15,560 shares at $39.06 per share.
Reporting Person Farquhar John C.M. · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 14, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0001464521-26-000133 · filed 2026-08-18 · View filing →
Sale of 22,562 shares at $28.31 per share.
Reporting Person Farquhar John C.M. · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001464521-26-000127 · filed 2026-08-12 · View filing →